Mineralocorticoid Receptor Antagonism in Patients With Atrial Fibrillation: Findings From the ORBIT‐AF (Outcomes Registry for Better Informed Treatment of Atrial Fibrillation) Registry

BackgroundMineralocorticoid receptor antagonist (MRA) therapy may be beneficial to patients with atrial fibrillation (AF), but little is known about their use in patients with AF and subsequent outcomes. Methods and ResultsIn order to better understand MRA use and subsequent outcomes, we performed a...

Повний опис

Бібліографічні деталі

Автори:	Marat Fudim, Peter R. Liu, Peter Shrader, Rosalia G. Blanco, Larry A. Allen, Gregg C. Fonarow, Bernard J. Gersh, Peter R. Kowey, Kenneth W. Mahaffey, Elaine Hylek, Alan S. Go, Laine Thomas, Eric D. Peterson, Jonathan P. Piccini
Формат:	Artigo
Мова:	Inglês
Опубліковано:	Wiley 2018-04-01
Серія:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Предмети:	atrial fibrillation mineralocorticoid antagonist stroke
Онлайн доступ:	https://www.ahajournals.org/doi/10.1161/JAHA.117.007987
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!